Exclusive

Publication

Byline

Location

Artelo Biosciences Enrolls First Patient In Phase 2 Glaucoma Study Of ART27.13

India, Aug. 10 -- Artelo Biosciences, Inc. (ARTL), a clinical-stage pharmaceutical company focused on lipid-signaling pathways, announced the enrollment of the first patient in the Phase 2 DREAM study... Read More


Rocket Lab USA Q2 26 Earnings Conference Call At 5:00 PM ET

India, Aug. 10 -- Rocket Lab USA, Inc. (RKLB) will host a conference call at 5:00 PM ET on August 10, 2026, to discuss Q2 26 earnings results. To access the live webcast, log on to https://investors.... Read More


Simon Property Group Q2 26 Earnings Conference Call At 5:00 PM ET

India, Aug. 10 -- Simon Property Group Inc (SPG) will host a conference call at 5:00 PM ET on August 10, 2026, to discuss Q2 26 earnings results. To access the live webcast, log on to https://investo... Read More


Crude Oil Skyrockets Amid Heightening Uncertainty Over Strait Of Hormuz Reopening

India, Aug. 10 -- Extending the sharp gains from Friday's session, crude oil prices have catapulted on Monday as expectations of an early reopening of the Strait of Hormuz began to fade following seve... Read More


SeaStar Medical Gains 13% Ahead Of Q2 Results As Critical Care Pipeline Advances

India, Aug. 10 -- Shares of SeaStar Medical Holding Corporation (ICU) are up 13% today as the company gears up to report its second-quarter 2026 financial results on August 12, with investors focused ... Read More


Faeth Therapeutics Gains 18% As PIKTOR Approaches Phase 2 Endometrial Cancer Data

India, Aug. 10 -- Shares of Faeth Therapeutics, Inc. (FTH) are up over 18% today. The company recently provided an update on its oncology pipeline and reported its second-quarter 2026 financial resul... Read More


Fastly Stock Gains 19% After Strong Q2 Results

India, Aug. 10 -- Fastly, Inc. (FSLY) shares rose $4.47, or 19.43 percent, to $27.42 on Monday, after the edge cloud platform company reported strong second-quarter results, with revenue increasing 23... Read More


AbCellera Stock Gains 37% On Positive Phase 2 Results

India, Aug. 10 -- AbCellera Biologics Inc. (ABCL) shares rose 37 percent to $9.47 on Monday after the company announced positive Phase 2 results for ABCL635, an investigational treatment for moderate-... Read More


Veru Gains 17% As Obesity Trial Exceeds Enrollment Target, Data Due In Q1, 2027

India, Aug. 10 -- Shares of Veru Inc. (VERU) are up 17.17% today, following financial results for its fiscal 2026 third quarter ended June 30, 2026, and an update on the progress of its clinical devel... Read More


Gold Edges Higher Amid Latest Jobs Data While U.S.-Iran Deal Remains Evasive

India, Aug. 10 -- Extending the gains from Friday's surge, gold prices have inched higher on Monday after expectations of a softer monetary policy by the U.S. Federal Reserve following the latest nonf... Read More